At the time of writing, Surgery Partners Inc [SGRY] stock is trading at $25.79, up 1.74%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SGRY shares have gain 0.55% over the last week, with a monthly amount glided 29.92%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Surgery Partners Inc [NASDAQ: SGRY] stock has seen the most recent analyst activity on December 16, 2024, when BofA Securities initiated its Buy rating and assigned the stock a price target of $30. Previously, UBS started tracking the stock with Buy rating on October 14, 2024, and set its price target to $38. On October 11, 2024, KeyBanc Capital Markets initiated with a Sector Weight rating. Macquarie started tracking the stock assigning a Outperform rating and suggested a price target of $31 on June 28, 2024. Barclays initiated its recommendation with a Equal Weight and recommended $35 as its price target on March 06, 2024. TD Cowen upgraded its rating to Outperform for this stock on November 14, 2023, and downed its price target to $35. In a note dated June 02, 2023, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $42 to $45.
For the past year, the stock price of Surgery Partners Inc fluctuated between $19.50 and $35.29. Currently, Wall Street analysts expect the stock to reach $36.33 within the next 12 months. Surgery Partners Inc [NASDAQ: SGRY] shares were valued at $25.79 at the most recent close of the market. An investor can expect a potential return of 40.87% based on the average SGRY price forecast.
Analyzing the SGRY fundamentals
According to Surgery Partners Inc [NASDAQ:SGRY], the company’s sales were 2.99B for trailing twelve months, which represents an 14.29% jump. Gross Profit Margin for this corporation currently stands at 0.21% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.03 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.86.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 25.40 points at the first support level, and at 25.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.08, and for the 2nd resistance point, it is at 26.38.
Ratios To Look Out For
It is important to note that Surgery Partners Inc [NASDAQ:SGRY] has a current ratio of 1.80. As well, the Quick Ratio is 1.66, while the Cash Ratio is 0.39. Considering the valuation of this stock, the price to sales ratio is 1.10, the price to book ratio is 1.73.
Transactions by insiders
Recent insider trading involved Bane Harrison R., National Group President, that happened on Feb 07 ’25 when 56315.0 shares were sold. Chief Financial Officer, Doherty David T completed a deal on Feb 07 ’25 to sell 13641.0 shares. Meanwhile, Chief Strategy Officer Brittenham Marissa sold 14700.0 shares on Feb 07 ’25.
